Prahallad A, Weiss A, Voshol H, Kerr G, et al. CRISPR screening identifies mechanisms of resistance to KRASG12C and SHP2 inhibitor combinations in non-small cell lung cancer. Cancer Res 2023 Nov 7. doi: 10.1158/0008-5472.CAN-23-1127.
PMID: 37934115